e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Diagnosis and predictors of COPD exacerbation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Any detectable admission cardiac troponin I level is associated with increased risk of early death following COPD exacerbations
P. R. Vamadevan, A. W. Hitchings, T. S. Grewal, D. Ahnood, E. H. Baker (London, United Kingdom)
Source:
Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Session:
Diagnosis and predictors of COPD exacerbation
Session type:
Oral Presentation
Number:
401
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. R. Vamadevan, A. W. Hitchings, T. S. Grewal, D. Ahnood, E. H. Baker (London, United Kingdom). Any detectable admission cardiac troponin I level is associated with increased risk of early death following COPD exacerbations. Eur Respir J 2011; 38: Suppl. 55, 401
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Relationships between elevated cardiac troponin levels in COPD exacerbations and subsequent cardiac investigation and management
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Acute exacerbation of COPD is associated with three-fold elevation of cardiac troponin T
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012
Elevated cardiac troponin I levels in acute pulmonary embolism predict increased long-term mortality
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005
Assessment of premature death risk after recovery from COPD exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Prognostic value of high troponin levels in acute COPD attack patients with respiratory insufficiency
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
BNP is a predictor of mortality following COPD exacerbations
Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Year: 2011
Elevated cardiac troponin predicts 11-year mortality in COPD
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020
High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Is a cardiopulmonary exercise test (CPET) associated with an increase in high sensitivity cardiac troponin T (hs-cTnT) levels in patients with COPD?
Source: International Congress 2017 – Lung function practice in daily life
Year: 2017
Cardiac troponin I elevation in the exacerbations of severe COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Evaluation of serum troponin level in exacerbation of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005
The significance of the adherence to the discharge criteria in patients with acute exacerbation of COPD on early readmission
Source: International Congress 2017 – COPD management
Year: 2017
Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
CAB score predicts short-term mortality at hospital admission for acute exacerbations of COPD
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011
Increased prevalence of elevated high-sensitivity cardiac troponin T among patients with stable chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept